| BSCB | Blood–spinal cord barrier |
| BMP | Bone morphogenetic protein |
| CSPG | Chondroitin sulfate proteoglycan |
| dECM | Decellularized extracellular matrix |
| ECM | Extracellular matrix |
| EV | Extracellular vesicle |
| FDA | Food and Drug Administration |
| GelMA | Gelatin methacryloyl |
| GMP | Good manufacturing practices |
| HA | Hyaluronic acid |
| hiPSCs | Human induced pluripotent stem cells |
| hESCs | Human embryonic stem cells |
| MEA | Microelectrode array |
| MMP | Matrix Metalloproteinases |
| NIST | National Institute of Standards and Technology |
| OoaC | Organoid-on-a-chip |
| OoC | Organ-on-a-chip |
| SCO | Spinal cord organoid |
| SCI | Spinal cord injury |
| SCO-OoaC | Spinal cord organoid-on-a-chip |
| SHH | Sonic hedgehog |
| TEER | Transepithelial/Transendothelial electrical resistance |
| VEGF | Vascular endothelial growth factor |
| WHO | World Health Organization |